Yale University

Julia Rozanova, PhD, an Associate Research Scientist within the Yale Clinical & Community Research (YCCR) at Yale School of Medicine, has received a K01 award from the National Institute on Drug Abuse (NIDA). The project, entitled Exploring the Feasibility of a Peer-Driven Intervention to Improve HIV Prevention Among Prisoners who Inject Drugs, will focus on prisoners in Kyrgyzstan, one of 8 countries world-wide providing comprehensive HIV prevention including methadone maintenance in prisons. The total award is $700,000 USD over five years.

After refining the protocol of a within-prison peer-driven intervention (PDI) to reduce HIV risk in prisons, Dr. Rozanova and her team will pilot the PDI to reduce HIV risk among HIV-negative prisoners who inject drugs by scaling up enrollment and retention in addiction treatment programs, and explore why the PDI is (or is not) effective using experimental ethnography and qualitative interviews with prisoners, prison staff members, and PDI implementers, to generate hypotheses attributing participants outcomes to the PDI to be tested in the future RCT within a fully-funded R01.



Published: Monday, March 25, 2019